The global flow diverters market is experiencing robust growth due to an increasing burden of neurovascular diseases, especially intracranial aneurysms, and a shift toward minimally invasive treatment methods. According to recent industry insights, the market was valued at USD 454.99 million in 2024 and is projected to reach USD 515.36 million by 2025. With an impressive CAGR of 13.4% from 2025 to 2034, the market is expected to hit USD 1,596.17 million by the end of 2034.
Market Overview
Flow diverters are endovascular devices primarily used for the treatment of large, giant, and wide-neck intracranial aneurysms. These stent-like implants redirect blood flow away from the aneurysm sac, promoting healing through thrombosis and endothelial growth across the aneurysm neck. Unlike traditional surgical clipping or coiling procedures, flow diversion offers a less invasive, longer-lasting solution with reduced procedural risks.
With increasing preference for catheter-based treatments, the flow diverters market is gaining momentum among interventional neuroradiologists and neurosurgeons. Growing adoption of advanced neurovascular embolization devices, expanding indications for use, and continuous innovation in device design are further fueling market expansion.
Key Market Growth Drivers
-
Rising Prevalence of Intracranial Aneurysms and Strokes
Globally, intracranial aneurysms affect an estimated 3–5% of the population, many of which go undiagnosed until rupture. The growing geriatric population and increasing hypertension cases are contributing to the rising incidence of aneurysms. Flow diverters are being increasingly adopted for their efficacy in treating complex and unruptured aneurysms that are not amenable to conventional treatments. -
Advancements in Flow Diverter Technology
Manufacturers are investing in R&D to enhance stent flexibility, radial force, pore density, and deliverability of flow diverters. Innovations such as hybrid braided designs, anti-thrombotic coatings, and bioresorbable stents are revolutionizing the neurointerventional field. These developments have improved safety profiles and expanded the eligibility of patients. -
Increasing Preference for Minimally Invasive Neurointerventions
Flow diversion is gaining popularity as a minimally invasive treatment alternative, offering quicker recovery and fewer complications compared to open surgical interventions. This shift in clinical practice, supported by positive long-term outcomes, is accelerating market adoption. -
Rising Investments and Approvals in Neurovascular Devices
Major medical device companies are increasingly focusing on the neurovascular segment through mergers, acquisitions, and product launches. Regulatory approvals for novel flow diverters across the U.S., Europe, and Asia-Pacific regions are creating a favorable environment for market growth. Furthermore, increasing funding for interventional neurology devices is supporting expansion.
Market Challenges
Despite strong growth prospects, the market faces several challenges. The high cost of flow diverter procedures, especially in low- and middle-income countries, limits access to advanced care. Additionally, the complexity of treatment requires specialized skills and training, leading to unequal availability of experienced neurointerventionists. Regulatory hurdles and the need for long-term clinical data to validate newer devices also slow down product approvals and adoption in some regions.
Moreover, post-operative complications such as delayed aneurysm rupture, in-stent thrombosis, or ischemic stroke still pose clinical concerns, necessitating strict patient selection and monitoring.
Key Companies in the Market
- Medtronic
- Stryker Corporation
- Johnson & Johnson (via its subsidiary, Neurovascular)
- Abbott Laboratories
- Terumo Corporation
- Penumbra, Inc.
- Asahi Intecc
- Balt Extrusion
- Cook Medical
- Endospan
- Neuroform
- EndoMed Systems
Market Segmentation
Flow Diverters Market, Flow Diverter Type Outlook (Revenue - USD Million, 2020-2034)- Pipeline Embolization Device (PED)
- Flow Modulation Device (FMD)
- Stent-Assisted Coiling (SAC)
- Others
- Intracranial Aneurysms
- Arteriovenous Malformations
- Carotid Artery Disease
- Others
- Nitinol
- Cobalt-Chromium Alloy
- Stainless Steel
- Others
- Over-the-Wire Delivery System
- Catheter-Based Delivery System
- Others
- North America
- Flow Diverter Type Outlook
- Pipeline Embolization Device (PED)
- Flow Modulation Device (FMD)
- Stent-Assisted Coiling (SAC)
- Others
- Application Outlook
- Intracranial Aneurysms
- Arteriovenous Malformations
- Carotid Artery Disease
- Others
- Material Outlook
- Nitinol
- Cobalt-Chromium Alloy
- Stainless Steel
- Others
- Delivery System Outlook
- Over-the-Wire Delivery System
- Catheter-Based Delivery System
- Others
- Flow Diverter Type Outlook
- Europe
- Flow Diverter Type Outlook
- Pipeline Embolization Device (PED)
- Flow Modulation Device (FMD)
- Stent-Assisted Coiling (SAC)
- Others
- Application Outlook
- Intracranial Aneurysms
- Arteriovenous Malformations
- Carotid Artery Disease
- Others
- Material Outlook
- Nitinol
- Cobalt-Chromium Alloy
- Stainless Steel
- Others
- Delivery System Outlook
- Over-the-Wire Delivery System
- Catheter-Based Delivery System
- Others
- Flow Diverter Type Outlook
- Asia Pacific
- Flow Diverter Type Outlook
- Pipeline Embolization Device (PED)
- Flow Modulation Device (FMD)
- Stent-Assisted Coiling (SAC)
- Others
- Application Outlook
- Intracranial Aneurysms
- Arteriovenous Malformations
- Carotid Artery Disease
- Others
- Material Outlook
- Nitinol
- Cobalt-Chromium Alloy
- Stainless Steel
- Others
- Delivery System Outlook
- Over-the-Wire Delivery System
- Catheter-Based Delivery System
- Others
- Flow Diverter Type Outlook
Explore More:
https://www.polarismarketresearch.com/industry-analysis/flow-diverters-marketConclusion
The global flow diverters market is on a steep growth trajectory, fueled by clinical demand for safer, effective, and less invasive treatments for intracranial aneurysms. As advancements in neurointervention continue to reshape stroke and aneurysm management, flow diverters are expected to play an increasingly vital role in modern neurosurgery. With continued investment in R&D, supportive regulatory frameworks, and growing awareness across emerging economies, the market is poised for sustained innovation and expansion over the next decade.
More Trending Latest Reports By Polaris Market Research: Transcatheter Aortic Valve Replacement (Tavr) Market 3D Bioprinting Market Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market Aesthetic Lasers Market Aesthetic Medicine Market Airway Management Devices Market Alopecia Market Alzheimer’s Therapeutics Market Ambulatory Care Services Market Wound Care Market Remote Surgery Technology Platforms Market Brain Monitoring Market Medical Lasers Market Microgreens Market Cancer Biomarkers Market Ophthalmic Loupes Market Fluid Management System Market Pet-Ct Scanner Market Functional Endoscopic Sinus Surgery Market Next-generation Sequencing Library Preparation Market Protein A, G and L Resins Market Prostaglandin Analogs Market Compartment Syndrome Treatment Market High Throughput Screening Market Spatial Proteomics Market